![John Rothman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Rothman
Technik-/Wissenschafts-/F&E-Leiter bei
RIZE ONCOLOGY INC.
Vermögen: 14 470 $ am 30.04.2025
Profil
John M.
Rothman is Chief Scientific Officer at Rize Oncology, Inc. since 2025.
Former positions include Senior Director at Schering-Plough Canada, Inc., EVP-Clinical & Scientific Operations at Advaxis, Inc. from 2011 to 2013, Chief Scientific Officer at Racura Oncology Ltd., and Executive Vice President-Product Development at Tyme Technologies, Inc. from 2020 to 2022.
Education includes a doctorate from Tulane University School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
RIZE ONCOLOGY INC. 1,32 % | 06.01.2025 | 1 000 000 ( 1,32 % ) | 14 470 $ | 30.04.2025 |
Aktive Positionen von John Rothman
| Unternehmen | Position | Beginn |
|---|---|---|
| RIZE ONCOLOGY INC. | Technik-/Wissenschafts-/F&E-Leiter | 09.01.2025 |
Ehemalige bekannte Positionen von John Rothman
| Unternehmen | Position | Ende |
|---|---|---|
| TYME TECHNOLOGIES, INC. | Corporate Officer/Principal | 01.02.2022 |
| RACURA ONCOLOGY LTD | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2019 |
| AYALA PHARMACEUTICALS, INC. | Geschäftsführer | 09.12.2011 |
Schering-Plough Canada, Inc.
 Schering-Plough Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical preparations | Direktor/Vorstandsmitglied | - |
Ausbildung von John Rothman
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
15
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Tyme Technologies, Inc.
 Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops cancer metabolism-based therapeutics | Health Technology |
Advaxis, Inc.
 Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer and infectious diseases | Health Technology |
Schering-Plough Canada, Inc.
Schering-Plough Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical preparations | Health Technology |
Tulane University School of Medicine
 Tulane University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Race Oncology Ltd.
 Race Oncology Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs for cancer | Health Technology |
GeneTether Therapeutics, Inc.
 GeneTether Therapeutics, Inc. BiotechnologyHealth Technology Develops gene editing therapies and platform | Health Technology |
